David Weaver

Chief Executive Officer at Aphex BioCleanse Systems
On the record
Represented by:

A Chief Executive with over 40 years of leadership in Domestic/International Manufacturing including Import/Export experience in creating high volume Patented Health Care solutions for sanitizing and desinfecting medical devices and hard surfaces. Product developments include sanitizing products for agriculture, mold remediation and wound care for animals. A non-alcohol hand sanitizer provides lasting protection using the latest chemistries for pesticide and dye free uses. Possess extensive business knowledge in Europe, Hong Kong, China, Taiwan, Japan, Korea, Phillipines, Malaysia and Singapore having managed manufacturing organizations from 10 to 3000 people. Adept at restructuring operations, including mergers and acquisitions to create efficient supply chains to create significant increases in throughput, improved inventory turns, decreased product cost, and reduced inventories in factories. Led multiple ERP systems implementations, including SAP, re-engineering business processes, streamlining operations, and reducing inventories by $200M while working as a Supply Chain Manager at Kodak. Directed hardware and software product development efforts leveraging process management and advanced engineering tools to improve development lead times by 4 to 6 months. Throughout career recognized as a hands-on manager that empowers teams; aligns strategy, actions, and measures; flawlessly executes fundamentals; and communicates with the workforce to consistently hit quality, cost, delivery, and service targets.

Recent Quotes
Sign up to view all
  • "While we unite to fight the COVID-19 pandemic together, we are proud to offer safe and effective water-based disinfecting products. We are humbled to share that while much of the world is facing deep economic hardships, Aphex is well-positioned for growth during this time due to our product offerings,"

    5 February 2021
  • article
    5 February 2021
Sign up to view all